So, the present study aims to evaluate the immunohistochemical expression of autophagy markers Beclin1 and LC3B in prostatic carcinoma and BPH and their association with the available clinicopathological parameters. The gene discussed is BECN1; the disease is benign prostatic hyperplasia.